These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1255661)

  • 1. Sturcture-activity relationship of daunorubicin and its peptide derivatives.
    Wilson DW; Grier D; Reimer R; Bauman JD; Preston JF; Gabbay EJ
    J Med Chem; 1976 Mar; 19(3):381-4. PubMed ID: 1255661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction specificity of the anthracyclines with deoxyribonucleic acid.
    Gabbay EJ; Grier D; Fingerle RE; Reimer R; Levy R; Pearce SW; Wilson WD
    Biochemistry; 1976 May; 15(10):2062-70. PubMed ID: 776212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new series of reductive amination derivatives of daunorubicin: syntheses, partition coefficients, and DNA binding.
    Yen SF; Wilson WD; Pearce SW; Gabbay EJ
    J Pharm Sci; 1984 Nov; 73(11):1575-9. PubMed ID: 6394744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunorubicin inhibition of DNA-dependent RNA polymerases from Ehrlich ascites tumor cells.
    Barthelemy-Clavey V; Molinier C; Aubel-Sadron G; Maral R
    Eur J Biochem; 1976 Oct; 69(1):23-33. PubMed ID: 991857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of daunorubicin analogues with novel 9-acyl substituents.
    Smith TH; Fujiwara AN; Henry DW
    J Med Chem; 1979 Jan; 22(1):40-4. PubMed ID: 423182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
    Kuśnierczyk H; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):259-62. PubMed ID: 3592929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches for designing antiviral and antitumor compounds.
    Chandra P
    Top Curr Chem; 1974; 52():99-139. PubMed ID: 4617340
    [No Abstract]   [Full Text] [Related]  

  • 8. Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity.
    Fiallo MM; Garnier-Suillerot A
    Biochemistry; 1986 Feb; 25(4):924-30. PubMed ID: 3964654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of sugar-ring hydroxyl analogues of daunorubicin.
    Fuchs EF; Horton D; Weckerle W; Winter-Mihaly E
    J Med Chem; 1979 Apr; 22(4):406-11. PubMed ID: 571021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of RNA polymerase by daunomycin.
    Zunino F; Di Marco A; Zaccara A; Luoni G
    Chem Biol Interact; 1974 Jul; 9(1):25-36. PubMed ID: 4605280
    [No Abstract]   [Full Text] [Related]  

  • 11. On the inhibition of the RNA polymerase-catalysed synthesis of RNA by daunomycin. Interference of the inhibitor with elongation and pre-longation steps.
    Kriebardis T; Meng D; Aktipis S
    Biochem Biophys Res Commun; 1984 Sep; 123(3):914-20. PubMed ID: 6487334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives.
    Di Marco A; Casazza AM; Gambetta R; Supino R; Zunino F
    Cancer Res; 1976 Jun; 36(6):1962-6. PubMed ID: 773533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
    Tong GL; Cory M; Lee WW; Henry DW
    J Med Chem; 1978 Aug; 21(8):732-7. PubMed ID: 690999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.
    Di Marco A; Casazza AM; Dasdia T; Necco A; Pratesi G; Rivolta P; Velcich A; Zaccara A; Zunino F
    Chem Biol Interact; 1977 Dec; 19(3):291-302. PubMed ID: 597963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.
    Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of the antitumor antibiotic danuorubicin. Coupling of the sugar and aglycone.
    Acton EM; Fujiwara AN; Henry DW
    J Med Chem; 1974 Jun; 17(6):659-60. PubMed ID: 4829947
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin analogs hydroxylated at c-3': synthesis and antitumor activity.
    Horton D; Turner WR
    Carbohydr Res; 1979 Dec; 77():C8-C11. PubMed ID: 519652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
    Povarov LS; Bakina EV; Lazhko EI; Orlova GI; Zhukova OS; Obidniak NA; Iurchenko GI; Glazkova TIu; Preobrazhenskaia MN
    Bioorg Khim; 1990 Apr; 16(4):559-68. PubMed ID: 2375780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
    Horton D; Priebe W; Varela O
    J Antibiot (Tokyo); 1984 Dec; 37(12):1635-41. PubMed ID: 6549317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
    Studzian K; Wasowska M; Piestrzeniewicz MK; Wilmańska D; Szmigiero L; Oszczapowicz I; Gniazdowski M
    Neoplasma; 2001; 48(5):412-8. PubMed ID: 11845988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.